The Europe Pain Management Devices Market was valued at USD 1.07 billion in 2024. The Europe Pain Management Devices Market is expected to have 7.9 % CAGR from 2025 to 2033 and be worth USD 2.12 billion by 2033 from USD 1.15 billion in 2025.
The growing elderly people population, growth in the diabetic population suffering from pain, and technological advancements are majorly driving the market growth.
Additionally, high disposable income and standard growth in joint and acute chronic illnesses further fuel the market. Furthermore, favorable reimbursement policies and growing R&D to develop new products are other factors significantly helping the market to improve further.The high cost of the devices and low knowledge levels about these products may hamper the European pain management devices market. Post-operative side effects like hypersensitivity reactions and redness of the skin are those caused by these pain management devices that mainly obstruct the market growth. Furthermore, strict rules to be followed for product launches and the manufacturing of these pain management devices may hinder the European region's market growth.
Based on the region, Europe ranks second in holding the most significant share of the global pain management devices market, followed by North America in 2024. The UK pain management devices market is expected to dominate the European market due to many key market participants. Among all the nations of Europe, nearly 11% of adults and 8% of children are suffering from chronic pain, which affects around one-third and one-half of the overall population across the UK, which leads to the market growth of pain management devices. The German pain management devices market is next to the UK in projecting at a healthy rate. The growing prevalence of chronic and acute patients suffering pains is majorly driving the market.
Companies playing a promising role in the European pain management devices market profiled in the report are St. Jude Medical, Inc., Boston Scientific Corporation, Medtronic plc, Baxter International, Stryker Corporation, Pfizer, Codman and Shurtleff, B Braun Melsungen AG, and DJO Global LLC.
By Device Type
Neurostimulation Devices
Transcutaneous Electrical Nerve Stimulation devices
Spinal Cord Stimulation devices
Ablation Devices
Radiofrequency Ablation Devices
Cryo Ablation Devices
Analgesia Infusion Pumps
Intrathecal Infusion Pumps
External Infusion Pumps
By Application
Neuropathic Pain
Facial Pain
Migraine
Musculoskeletal Pain
Cancer Pain
Others
By Mode of Purchase
Counter Purchase
Prescription Based Purchase
By Country
UK
France
Spain
Germany
Italy
Russia
Sweden
Denmark
Switzerland
Netherlands
Turkey
Czech Republic
Rest of Europe
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region